FIELD: medicine, pharmaceutics.
SUBSTANCE: in claimed invention it suggested are liposome compositions, which contain substituted ammonia and/or polyanion and, optionally, desirable therapeutic agent or expressing contrast substance.
EFFECT: invention provides efficient method of obtaining liposome compositions.
141 cl, 40 tbl, 74 ex, 47 dwg
Title | Year | Author | Number |
---|---|---|---|
LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2732567C2 |
COMBINATION LIPOSOMAL COMPOSITIONS FOR CANCER TREATMENT | 2012 |
|
RU2640934C2 |
HYDRATED CRYSTALLINE CAMPTOTHECIN ESTERS FOR TREATING CANCER | 2008 |
|
RU2483071C2 |
PROLONGED RELEASE OF NEUREGULIN FOR IMPROVEMENT IN CARDIAC FUNCTION | 2006 |
|
RU2457854C2 |
LIPOSOMAL COMPOSITION AND METHOD OF ITS PREPARATION | 2012 |
|
RU2514000C1 |
METHOD OF PREVENTION AND/OR TREATMENT OF CANCEROUS DISEASES | 2006 |
|
RU2480201C2 |
LIPOSOMAL COMPOSITIONS AND SOLID PERORAL MEDICINAL FORMS COMPRISING SUCH COMPOSITIONS | 2018 |
|
RU2751192C2 |
NOVEL COMPOSITIONS OF LIPIDS AND STABILIZING MATERIALS | 1996 |
|
RU2181998C2 |
Authors
Dates
2011-07-27—Published
2005-05-02—Filed